DEC 2013

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/227001

Contents of this Issue


Page 10 of 74

BSS PLUS® IRRIGATING SOLUTION BRIEF SUMMARY OF PRESCRIBING INFORMATION DESCRIPTION: BSS PLUS®, a sterile intraocular irrigating solution, is used during all intraocular surgical procedures, including those requiring a relatively long intraocular perfusion time (e.g., pars plana vitrectomy, phacoemulsifcation, extracapsular cataract extraction/lens aspiration, anterior segment reconstruction, etc.). The solution does not contain a preservative and should be prepared just prior to use in surgery. INDICATIONS AND USAGE: BSS PLUS® Irrigating Solution is indicated for use as an intraocular irrigating solution during intraocular surgical procedures involving perfusion of the eye. CONTRAINDICATIONS: There are no specifc contraindications to the use of BSS PLUS® Irrigating Solution; however, contraindications for the surgical procedure during which BSS PLUS® Irrigating Solution is to be used should be strictly adhered to. WARNINGS: For IRRIGATION during ophthalmic surgery only. Not for injection or intravenous infusion. Do not use unless product is clear, seal is intact, vacuum is present and container is undamaged. Do not use if product is discolored or contains a precipitate. PRECAUTIONS: DO NOT USE BSS PLUS® IRRIGATING SOLUTION UNTIL PART I IS FULLY RECONSTITUTED WITH PART II. Discard unused contents. BSS PLUS® Irrigating Solution does not contain a preservative; therefore, do not use this container for more than one patient. Do not use additives other than BSS PLUS® Irrigating Solution Concentrate Part II (20 mL) with this product. Tissue damage could result if other drugs are added to product. DISCARD ANY UNUSED PORTION SIX HOURS AFTER PREPARATION. Studies suggest that intraocular irrigating solutions which are iso-osmotic with normal aqueous fuids should be used with caution in diabetic patients undergoing vitrectomy since intraoperative lens changes have been observed. There have been reports of corneal clouding or edema following ocular surgery in which BSS PLUS® Irrigating Solution was used as an irrigating solution. As in all surgical procedures appropriate measures should be taken to minimize trauma to the cornea and other ocular tissues. Geriatric Use: No overall diferences in safety or efectiveness have been observed between elderly and younger patients. ADVERSE REACTIONS: Postoperative infammatory reactions as well as incidents of corneal edema and corneal decompensation have been reported. Their relationship to the use of BSS PLUS® Irrigating Solution has not been established. OVERDOSAGE: The solution has no pharmacological action and thus no potential for overdosage. However, as with any intraocular surgical procedure, the duration of intraocular manipulation should be kept to a minimum. © 2013 Novartis 10/13 BSS13006JAD-PI December 2013 ASCRS•ASOA continued from page 3 The evening non-CME session "Comprehensive Video Presentation" will feature Dr. Osher as instructor, running from 5:30 p.m. to 6:30 p.m. Physicians scheduled to moderate or instruct on Saturday include Roger F. Steinert, MD, professor of ophthalmology, University of California, Irvine; Eric D. Donnenfeld, MD, co-chairman, cornea, Nassau University Medical Center, East Meadow, N.Y.; Brock K. Bakewell, MD, Fishkind, Bakewell and Maltzman Eye Care and Surgery Center, Tucson, Ariz., and clinical assistant professor of ophthalmology, University of Utah; Keith A. Warren, MD, president and CEO, Warren Retina Associates, Overland Park, Kansas; and Nick Mamalis, MD, professor of ophthalmology, John A. Moran Eye Center, ophthalmology department, University of Utah, Salt Lake City. On Sunday, David F. Chang, MD, clinical professor of ophthalmology, University of California, San Francisco, will open the day at 8 a.m. moderating "My Top Five Pearls." Glaucoma will enter the mix from 10:30 a.m. until 12:30 p.m. with "Updating Your Glaucoma Treatment Armamentarium," moderated by Richard A. Lewis, MD, Sacramento, Calif., and Thomas W. Samuelson, MD, Minnesota Eye Consultants, Minneapolis. Optional workshops that afternoon will also feature cornea and glaucoma case management. E. Ann Rose, president, Rose & Associates, Duncanville, Texas, is scheduled to present "ASOA for MDs: Medicare Update" from 5:30 p.m. until 6:30 p.m. On Monday, Dr. Donnenfeld, John D. Banja, PhD, medical ethicist, Center of Ethics, Emory University, Atlanta, and Dr. Steinert will moderate three separate sessions starting at 7 a.m. "This more intimate and casual educational event combines highenergy sessions with video cases, debates, and discussion," officials said. "You will come away refreshed and energized by new knowledge and insight that will have an immediate impact on your practice." For more information, visit winterupdate.org. EW

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - DEC 2013